World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
137
Citations
66813
World Ranking
1912
National Ranking
1086

Pal Pacher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pal Pacher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 450 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pal Pacher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pal Pacher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 137 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pal Pacher is a researcher affiliated with the National Institutes of Health in the United States. Their scientific contributions span multiple disciplines, with a primary focus on medicine and biochemistry, genetics, and molecular biology. Their work particularly emphasizes physiology, pharmacology, molecular biology, surgery, and epidemiology as notable subfields of study.

The research topics that Pal Pacher has extensively investigated include:

  • Cannabis and Cannabinoid Research
  • Alcohol Consumption and Health Effects
  • Adenosine and Purinergic Signaling
  • Liver Disease Diagnosis and Treatment
  • Pancreatic function and diabetes
  • Biochemical effects in animals
  • Lipoproteins and Cardiovascular Health

Among recent publications, the following papers represent significant contributions to their research portfolio:

  • Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis, 2020, Journal of Clinical Investigation
  • PARPs in lipid metabolism and related diseases, 2021, Progress in Lipid Research
  • Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications, 2020, Nature Reviews Cardiology
  • Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice, 2020, Nature Chemical Biology
  • Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury, 2021, Journal of Clinical Investigation

Pal Pacher has collaborated frequently with several scientists, including:

  • György Haskó (23 coauthored publications)
  • János Pálóczi (14 coauthored publications)
  • Uwe Grether (13 coauthored publications)
  • Partha Mukhopadhyay (11 coauthored publications)
  • Mario van der Stelt (10 coauthored publications)

The main publication venues for Pal Pacher's research include:

  • GeroScience (8 publications)
  • American Journal Of Pathology (3 publications)
  • Journal of Clinical Investigation (2 publications)
  • Nature Communications (2 publications)
  • The FASEB Journal (2 publications)

In addition to journal articles, Pal Pacher has contributed to book publications. One notable work is the 2022 publication titled Therapeutic Potential of the Cannabinoid CB2 Receptor, published by Frontiers Media.

Best Publications

  • Nitric Oxide and Peroxynitrite in Health and Disease

    Pál Pacher;Joseph S. Beckman;Lucas Liaudet

  • The Endocannabinoid System as an Emerging Target of Pharmacotherapy

    Pál Pacher;Sándor Bátkai;George Kunos

  • Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

    Pál Pacher;Alex Nivorozhkin;Csaba Szabó;Csaba Szabó

  • Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

    György Haskó;Joel Linden;Bruce Cronstein;Pál Pacher

  • Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

    Douglas Osei-Hyiaman;Michael DePetrillo;Pál Pacher;Jie Liu

  • CD39 and CD73 in immunity and inflammation

    Luca Antonioli;Pál Pacher;E. Sylvester Vizi;E. Sylvester Vizi;György Haskó

  • NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

    Oleg V. Evgenov;Pál Pacher;Peter M. Schmidt;György Haskó

  • Activation of the peripheral endocannabinoid system in human obesity.

    Stefan Engeli;Jana Böhnke;Mareike Feldpausch;Kerstin Gorzelniak

  • Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

    Pál Pacher;Takahiro Nagayama;Partha Mukhopadhyay;Sándor Bátkai

  • Immunity, inflammation and cancer: a leading role for adenosine

    Luca Antonioli;Corrado Blandizzi;Pál Pacher;György Haskó;György Haskó

  • Endocannabinoid signaling at the periphery: 50 years after THC

    Mauro Maccarrone;Itai Bab;Tamás Bíró;Guy A. Cabral

  • Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

    Nitin Agarwal;Pal Pacher;Irmgard Tegeder;Fumimasa Amaya

  • Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity

    Matthias Blüher;Stefan Engeli;Nora Klöting;Janin Berndt

  • Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

    Johannes-Peter Stasch;Pál Pacher;Oleg V. Evgenov

  • Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

    Mohanraj Rajesh;Partha Mukhopadhyay;Sándor Bátkai;Vivek Patel

  • Is lipid signaling through cannabinoid 2 receptors part of a protective system

    P. Pacher;R. Mechoulam

  • Evidence for novel cannabinoid receptors.

    Malcolm Begg;Pál Pacher;Sándor Bátkai;Douglas Osei-Hyiaman

  • Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?

    Pal Pacher;Pal Pacher;Valeria Kecskemeti

  • Drug-induced mitochondrial dysfunction and cardiotoxicity.

    Zoltán V Varga;Peter Ferdinandy;Lucas Liaudet;Pál Pacher

  • Basic Science for Clinicians Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

    Johannes-Peter Stasch;Pal Pacher;Oleg V. Evgenov

Frequent Co-Authors

György Haskó
György Haskó Columbia University
Csaba Szabó
Csaba Szabó University of Fribourg
Lucas Liaudet
Lucas Liaudet University of Lausanne
Sandor Batkai
Sandor Batkai Cardior Pharmaceuticals
George Kunos
George Kunos National Institutes of Health
Zoltan Ungvari
Zoltan Ungvari University of Oklahoma Health Sciences Center
Bin Gao
Bin Gao National Institutes of Health
Anna Csiszar
Anna Csiszar University of Oklahoma Health Sciences Center
László Virág
László Virág University of Debrecen
Ken Mackie
Ken Mackie Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical school in the USA but are also exploring alternative or supporting career paths, there are several online degree options worth considering. For those interested in a nursing career, pursuing the easiest bsn program to get into might provide a more accessible entry point into healthcare without the steep competition or advanced prerequisites of traditional medical schools.

Another in-demand field is medical administration and support services. Many students find success in medical coding and billing classes online with financial aid, gaining job-ready skills for roles in medical offices, hospitals, or insurance companies. These programs are often flexible and designed for working adults.

If you already hold an LPN license, several lpn to rn programs without teas test can bridge the gap to a higher level of nursing without requiring additional entrance exams. Alternatively, an online healthcare administration degree provides foundational business and leadership skills for managing healthcare facilities, opening doors beyond clinical roles.

Exploring these online degrees can offer more flexible, affordable, and diverse pathways into the healthcare sector—all without the traditional barriers of medical school.

Best Scientists Citing Pal Pacher

Trending Scientists

Recently Published Articles